Steris Plc's ability to collect accounts receivable sequentially worsen to 6.04, indicating more challenging environment then in the third quarter 2023, but still, it is a far cry from any concerns. Average collection period, for Steris Plc's accounts receivable remained unchanged at 60 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 325 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from to 2716.

What is Receivable Turnover Ratio?
What is Steris Plc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

STE31 Receivables Turnover Ratio	(Jun 30 2026) I. Quarter	(Dec 31 2022) III. Quarter	(Sep 30 2022) II. Quarter	(Jun 30 2022) I. Quarter	(Mar 31 2022) IV. Quarter
Y / Y Receivable Change	26.8 %	31.12 %	2.38 %	2.74 %	31.12 %
Y / Y Revenue Change	23.29 %	0.58 %	0.3 %	19.42 %	38.6 %
Receivable Turnover Ratio (TTM)	6.04	6.09	6.47	6.51	6.29
STE31's Total Ranking	# 2716	#	#	#	#
Accounts Receivable average collection period days	60	60	56	56	58
Seq. Receivable Change	26.8 %	2.43 %	2.14 %	-4.41 %	31.12 %
Seq. Revenue Change	22.76 %	1.29 %	3.81 %	-4.48 %	0.14 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 133
Healthcare Sector	# 326
Overall Market	# 2716

Receivable Turnover Ratio Statistics
High	Average	Low
0.57	0.44	0.14
(Mar 31 2020)		(Jun 30 2019)

STE31 Company Profile • Back to STE31 Efficiency Comparisons • Compare STE31 Receivables Turnover Ratio to its Competitors

Financial Statements
Steris Plc's Accounts Receivable	$ 1,013 Millions	Visit STE31's Balance sheet
Steris Plc's Sales TTM	$ 5,066 Millions	Visit STE31's Income Statement
Sources of STE31's Revenues		Visit STE31's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
STE31's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
STE31's Growth Rates	STE31's Roa	STE31's Inventory Turnover Ratio	STE31's Dividend Comparisons
STE31's Profitability Ratios	STE31's Roi	STE31's Asset Turnover Ratio	STE31's Dividend Growth
STE31's Valuation Ratios	STE31's Roe	STE31's Financial Strength Ratios	STE31's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Arvinas Inc	13.49	$ 316.700 Millions	$ 23.475 Millions
Rosecliff Acquisition Corp I	13.43	$ 16.467 Millions	$ 1.226 Millions
Corcept Therapeutics Inc	13.30	$ 830.813 Millions	$ 62.477 Millions
Precipio inc	13.25	$ 27.198 Millions	$ 2.052 Millions
Chemed Corporation	12.94	$ 2,595.001 Millions	$ 200.565 Millions
Qhslab Inc	12.77	$ 3.017 Millions	$ 0.236 Millions
Petvivo Holdings Inc	12.34	$ 1.182 Millions	$ 0.096 Millions
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions
Milestone Scientific Inc	11.82	$ 8.855 Millions	$ 0.749 Millions
Marpai Inc	11.71	$ 16.635 Millions	$ 1.420 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Nrc Health	11.35	$ 139.996 Millions	$ 12.337 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Premier Air Charter Holdings Inc	10.66	$ 31.562 Millions	$ 2.961 Millions
C4 Therapeutics Inc	10.65	$ 35.039 Millions	$ 3.290 Millions
Lifeloc Technologies Inc	10.48	$ 9.269 Millions	$ 0.884 Millions
Immucell Corporation	10.29	$ 29.777 Millions	$ 2.893 Millions
Addus Homecare Corp	10.23	$ 1,475.610 Millions	$ 144.195 Millions
Radnet Inc	10.11	$ 2,268.932 Millions	$ 224.447 Millions
Utah Medical Products Inc	9.88	$ 35.679 Millions	$ 3.612 Millions
Lensar Inc	9.75	$ 60.264 Millions	$ 6.184 Millions
Encompass Health Corporation	9.57	$ 6,206.100 Millions	$ 648.325 Millions
Alumis inc	9.44	$ 7.398 Millions	$ 0.784 Millions
Enanta Pharmaceuticals Inc	9.29	$ 65.258 Millions	$ 7.027 Millions
Harmony Biosciences Holdings inc	9.22	$ 960.191 Millions	$ 104.164 Millions
Pavmed Inc	9.16	$ 0.126 Millions	$ 0.014 Millions
Ardent Health Inc	9.16	$ 6,405.940 Millions	$ 699.363 Millions

Date modified: 2026-09-05T07:08:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.